We have served over 800 satisfied customers. Our clients include investors (about 45%) and companies (about 55%).
Have a look at our non-confidential list of investors and companies to get an idea of what we can do for you.
Celtic Pharma Holdings II L.P
European Investment Bank (EIB)
HP / NCICube
Novartis Venture Fund
UK and France
Unirisco / Uninvest
APR Applied Pharma Research
Arpida / Evolva
Discovery Genomics Inc.
Sinus Point AG
Swiss Pharma Contract
Thommen Medical AG
Viron Therapeutics Inc.
What our client says
Our experience with Venture Valuation was collegial, even during the occasional differences of perspective, which are inevitable. We found the ultimate valuation to be fair and comprehensive.
Venture Valuation helped us to independently value a large number of companies in a structured and reproduceable manner, providing transparency and clear basis for decisions. Great team to work with!
We found that the reports were of excellent quality. We can recommend Venture Valuation to all parties that have a need for valuation. We are considering to request further valuations from Venture Valuation.
Professional service, great interaction with the client, delivery of report according to timelines
Straight forward interaction with the Venture Valuation's team.
Impressed by fast turn around and delivery in time of a complex content case.
In addition to a report which exceeded expectations, the whole process pushed us to review some of the options we initially considered. I strongly recommend the exercise.
Venture Valuation provides a well-structured, independent opinion on the company's valuation, supported by a detailed report demonstrating their understanding of the company.